Language Select
Varian Logo

Neueste Nachrichten

Oktober 08, 2019
Varian (NYSE: VAR) will showcase the company's interventional oncology solutions at the Symposium on Clinical Interventional Oncology, October 11-13, 2019 in Miami, Fla. The Varian interventional... Read more
September 23, 2019
Varian (NYSE: VAR) today announced the United States Trade Representative (USTR) has granted exclusion of components sourced from China for linear accelerators manufactured in the U.S from Section... Read more
September 16, 2019
Varian (NYSE: VAR) has named Francis R. Facchini, M.D., FSIR, as the new chief medical officer, Interventional Oncology, reporting to Dee Khuntia, Varian chief medical officer. Effective September... Read more

Neueste Blog-Posts

Okt. 04, 2019 | Centerline
In May of this year, Varian completed the global release of ARIA eDoc, a PDF software printer application for the ARIA® oncology information system for radiation oncology, designed to help ease the... Read more
Sept. 05, 2019 | Centerline
Historically there has been one practical option for dealing with interfraction and intrafraction motion during stereotactic body radiotherapy (SBRT): Increase the clinical target volume. Doing so,... Read more
Aug. 20, 2019 | Centerline
Varian introduced the Bravos afterloader system at ASTRO in 2018, in response to a growing need for an easy-to-use, efficient system. In this article, the clinical team at the UK-based Norfolk and... Read more

Erhalten Sie Nachrichtenmitteilungen per E-Mail
Jetzt abonnieren

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com